|
GEO ID | Comparison | Cell/tissue | No. of samples | PMID |
|
GSE59226 | Influenza virus-infected vs. inactivate virus-infected | Human umbilical vein ECs | 2/2 | 25863179 |
|
GSE1377 | Kaposi sarcoma-associated herpes virus-infected for 7 days vs. uninfected control | Primary human dermal ECs | 2/2 | 15220917 |
|
GSE5883 | 10 ng LPS stimulation for 4 hours vs. no LPS stimulation | Human lung microvascular ECs | 4/4 | NA |
10 ng LPS stimulation for 8 hours vs. no LPS stimulation | Human lung microvascular ECs | 4/4 | NA |
10 ng LPS stimulation for 24 hours vs. no LPS stimulation | Human lung microvascular ECs | 4/4 | NA |
|
GSE3920 | 1000 IU IFNα treated for 5 hours vs. untreated control | Human umbilical vein ECs | 5/5 | 17202376, 19553003 |
1000 IU IFNβ treated for 5 hours vs. untreated control | Human umbilical vein ECs | 2/5 | 17202376, 19553003 |
1000 IU IFNγ treated for 5 hours vs. untreated control | Human umbilical vein ECs | 3/5 | 17202376, 19553003 |
|
GSE85987 | NOTCH1 siRNA vs. scrambled control siRNA | Human umbilical vein ECs | 3/3 | 29449332 |
NOTCH1 siRNA+IL-1β treated 24 hours vs. scrambled siRNA | Human umbilical vein ECs | 3/3 | 29449332 |
|
GSE72633 | NOTCH1 siRNA vs. scrambled control siRNA | Human aortic ECs | 3/3 | 26552708 |
oxPAPC treated vs. scrambled control siRNA | Human aortic ECs | 3/3 | 26552708 |
|
GSE26953 | Oscillatory shear vs. laminar shear (fibrosa) | Human aortic valvular ECs | 6/6 | 21705672 |
Oscillatory shear vs. laminar shear (ventricularis) | Human aortic valvular ECs | 6/6 | 21705672 |
|
GSE39264 | apoE KO vs. WT | Mouse aortic ECs | 4/6 | 23990205 |
LPS treated for 4 hours vs. DMEM treated for 4 hours | Mouse aortic ECs | 3/3 | 23990205 |
oxLDL treated for 4 hours vs. DMEM treated for 4 hours | Mouse aortic ECs | 3/3 | 23990205 |
oxPAPC treated for 4 hours vs. DMEM treated for 4 hours | Mouse aortic ECs | 3/3 | 23990205 |
|